Registered Uganda · NDA

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT.ADSORBED)

NDA/MAL/HDP/0142 PARENTERAL ORDINARY VIALS 2.2MCG OF POLYSACCHARIDE FOR SEROTYPES 1,3,4,5,6A,7F.9V,14,18C,19A,19F,23F,AND 4.4MCG FOR SEROTYPE 6B

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

NDA/MAL/HDP/0142

Registration date

01/07/2011

Expiry date

Status

Registered

Active ingredient

Dosage form

PARENTERAL ORDINARY VIALS

Strength

2.2MCG OF POLYSACCHARIDE FOR SEROTYPES 1,3,4,5,6A,7F.9V,14,18C,19A,19F,23F,AND 4.4MCG FOR SEROTYPE 6B

Pack size

1.0X0.5 ML VIAL (1 DOSE)

Therapeutic class

Manufacturer / MAH

Pfizer Manufacturing Belgium NV

Applicant / LTR

PFIZER LABORATORIES

Country of origin

UNITED STATES| BELGIUM

Manufacturer location

Rijksweg 12, 2870 Puurs-Sint-Amands, Belgium

Source: National Drug Authority · fetched 2026-04-21 17:37:05 · updated 2026-09-12 04:00:19

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.